Cargando…
The Effect of Memantine Versus Folic Acid on Cognitive Impairment in Patients with Schizophrenia: A Randomized Clinical Trial
Objective: Schizophrenia, as one of the most severe psychiatric diseases, has a chronic and debilitating process. The majority of patients with schizophrenia do not respond adequately to treatment with common antipsychotic drugs. Therapeutic problems induced by drug side effects as well as undesired...
Autores principales: | Hosseini, Seyed Ahmad, Sepehrmanesh, Zahra, Gilasi, Hamidreza, Ghoraishi, Fatemeh Sadat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Psychiatry & Psychology Research Center, Tehran University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422942/ https://www.ncbi.nlm.nih.gov/pubmed/37575608 http://dx.doi.org/10.18502/ijps.v18i3.13002 |
Ejemplares similares
-
The effects of combined sertraline and aspirin therapy on depression severity among patients with major depressive disorder: A randomized clinical trial
por: Sepehrmanesh, Zahra, et al.
Publicado: (2017) -
Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine
por: Koola, Maju Mathew
Publicado: (2016) -
Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study
por: Lee, Jung Goo, et al.
Publicado: (2012) -
Critics on "Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study"
por: Pae, Chi-Un
Publicado: (2013) -
Tackling Negative Symptoms of Schizophrenia with Memantine
por: Paraschakis, Antonios
Publicado: (2014)